Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis
Abstract Background Gastric cancers frequently overexpress the epidermal growth factor receptor (EGFR), which has been implicated in pathological processes including tumor cell motility, invasion and metastasis. Targeting EGFR with the inhibitory antibody cetuximab may affect the motile and invasive...
Main Authors: | Simone Keller, Julia Kneissl, Verena Grabher-Meier, Stefan Heindl, Jan Hasenauer, Dieter Maier, Julian Mattes, Peter Winter, Birgit Luber |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3822-3 |
Similar Items
-
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines
by: Karolin Ebert, et al.
Published: (2020-10-01) -
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
by: Zhang X, et al.
Published: (2017-01-01) -
Management of Gastric Motility Disorder
by: Mustika Dian Permana, et al.
Published: (2018-04-01) -
Epidermal growth factor receptor (EGFR) mutation status and Rad51 determine the response of glioblastoma (GBM) to multimodality therapy with cetuximab, temozolomide and radiation
by: Phyllis Rachelle Wachsberger, et al.
Published: (2013-02-01) -
Nitric Oxide: From Gastric Motility to Gastric Dysmotility
by: Eglantina Idrizaj, et al.
Published: (2021-09-01)